Clinical depression, antidepressant use and risk of future cardiovascular disease

Iffat Rahman1, Keith Humphreys, Anna Michaela Bennet

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 17177, Stockholm, Sweden. Iffat.Rahman@ki.se

Insights

Depression increases cardiovascular disease (CVD) risk, particularly ischemic stroke. Depressed individuals not using antidepressants faced the highest CVD risk, suggesting depression is a significant risk factor.

Area of Science:

  • Epidemiology
  • Psychiatry
  • Cardiology

Background:

  • Depression is linked to increased cardiovascular disease (CVD) risk.
  • Previous research on antidepressants and CVD yields conflicting results.
  • Studies predominantly focus on coronary heart disease over stroke.

Purpose of the Study:

  • Investigate the association between depression, antidepressant use, and CVD development.
  • Differentiate the impact of depression on coronary heart disease versus ischemic stroke.
  • Clarify the role of untreated depression in CVD risk.

Main Methods:

  • Population-based cohort study of 36,654 Swedish elderly twins.
  • Follow-up period of up to 4 years.
  • Data collected from national patient and drug registries, and the Swedish twin registry.

Main Results:

  • Both depression and antidepressant use were associated with increased CVD risk.
  • The highest risk was observed in depressed patients not using antidepressants (HR 1.48).
  • Depression showed a significant association with ischemic stroke, but not coronary heart disease.

Conclusions:

  • Depression is a significant risk factor for cardiovascular disease development, especially ischemic stroke.
  • Untreated depression poses the highest risk for CVD outcomes.
  • The link between depression and CVD is more pronounced for stroke than for coronary heart disease.

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...